Alzheimers Research and Therapy Impact Factor, Indexing, Ranking

Alzheimers Research and Therapy (ARr) is a scholarly journal dedicated to publishing research in the field of Neuroscience. BioMed Central is the publisher of this esteemed journal. The P-ISSN assigned to Alzheimers Research and Therapy is 1758-9193 and its abbreviated form is Alzheimers Res Ther.

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports.

Although the primary focus is Alzheimer's disease, the scope encompasses translational research into other neurodegenerative diseases.

Alzheimers Research and Therapy Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Alzheimers Research and Therapy Journal is Alzheimers Res Ther.

The Ranking of Alzheimers Research and Therapy in 2023 is 779. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.

The Impact Factor of Alzheimers Research and Therapy in 2023 is 9.2. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors

The SCImago of Alzheimers Research and Therapy in 2023 is 2.650. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.

The H-Index of Alzheimers Research and Therapy in 2023 is 88. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.

The Quartile of Alzheimers Research and Therapy is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.

The Alzheimers Research and Therapy is indexed in (Indexing details)

• 1. Web of Science
• 2. UGC
• 3. Scopus
• 4. PubMed
• 5. Medline
• 6. Google Scholar

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.

The Editor-in-chief of Alzheimers Research and Therapy is Delphine Boche, University of Southampton, UK

Alzheimers Research and Therapy Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of Alzheimers Research and Therapy is £2590.00, $3690.00, €2990.00

Alzheimers Research and Therapy Call for paper : Alzheimers Research and Therapy invites original research contributions for consideration of publication in Alzheimers Research and Therapy journal.

Journal seeking submissions in the broad areas of Neuroscience that align with journal's focus on Neuroscience.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.

Publishing in Alzheimers Research and Therapy involves the following steps:

• Research: Conduct high-quality, impactful research in the field of Neuroscience.
• Familiarize Yourself: Read and understand the aims and scope of Alzheimers Research and Therapy to ensure your work aligns with their focus.
• Manuscript Preparation: Prepare your manuscript according to the Alzheimers Research and Therapy guidelines, including formatting, length, and referencing style.
• Submission: Submit your manuscript through the journal's online submission system.

• Journal Website
• PubMed
• Scopus
• SCImago